Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592344 · ClinicalTrials.gov registry record · NA
Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy
A NA study, sponsored by Bioness.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT01592344 is a NA study that has completed, run by Bioness. The registered enrollment target is 94 participants.
The verdict
NCT01592344, a NA study, has completed, sponsored by Bioness.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether the StimRouter (SR) electrical stimulation therapy leads to clinically important pain relief in patients with chronic intractable pain of peripheral nerve origin after three months of treatment. At the same time, this study will gather information on side effects associated with the StimRouter electrical stimulation therapy.
Interventions
- DEVICE StimRouter - active stimulation
- DEVICE StimRouter - Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01592344
The ClinicalTrials.gov registry entry for NCT01592344 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bioness, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which StimRouter - active stimulation is the first listed.
NCT01592344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01592344 about?
NCT01592344 is a clinical study titled "Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy". The purpose of this study is to investigate whether the StimRouter (SR) electrical stimulation therapy leads to clinically important pain relief in patients with chronic intractable pain of peripheral nerve origin after three months of treatment. At the same time, this study will gather information ...
What is the current status of trial NCT01592344?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2012-04. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01592344?
The interventions under investigation include: StimRouter - active stimulation (DEVICE), StimRouter - Control (DEVICE).
Who is sponsoring clinical trial NCT01592344?
This trial is sponsored by Bioness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.